Literature DB >> 19304092

Comparison of early postoperative clinical outcomes of photorefractive keratectomy and lamellar epithelial debridement.

Dong Ju Youm1, Hungwon Tchah, Chul Young Choi.   

Abstract

PURPOSE: To compare early postoperative clinical outcomes of photorefractive keratectomy (PRK) and lamellar epithelial debridement (LED).
SETTING: Department of Ophthalmology, Kangbuk Samsung Hospital, Seoul, Korea.
METHODS: This prospective study was of patients randomly assigned to have PRK or LED. In the LED group, an epithelial flap was created using an Amadeus II epikeratome. Postoperative follow-up was at 1, 3, and 7 days and 1, 3, and 6 months. The outcome parameters were uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), higher-order aberrations (HOAs), epithelial healing time, and corneal haze.
RESULTS: The study comprised 39 patients (76 eyes). The mean preoperative spherical equivalent (SE) was -3.96 diopters (D) +/- 1.24 (SD) in the PRK group and -4.06 +/- 1.39 D in the LED group. Postoperative UCVA was significantly better in the LED group 1 day postoperatively. The UCVA was 20/20 or better in 14.6% in the PRK group and 42.9% in the LED group (P = .006); 20/25 or better in 41.5% and 82.9%, respectively (P = .000); and 20/40 or better in 80.5% and 100%, respectively (P = .006). On subsequent follow-up visits, the UCVA was comparable between groups. No eye lost lines of BCVA at 3 months. There was no difference between groups in postoperative SE refraction, HOAs, or corneal haze.
CONCLUSIONS: Lamellar epithelial debridement and PRK had comparable safety and efficacy in the surgical correction of low to moderate myopia. The UCVA was significantly better after LED than after PRK 1 day postoperatively and equivalent thereafter.

Entities:  

Mesh:

Year:  2009        PMID: 19304092     DOI: 10.1016/j.jcrs.2008.12.018

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  1 in total

1.  Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes.

Authors:  Christopher S Sáles; Edward E Manche
Journal:  Clin Ophthalmol       Date:  2019-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.